Anthracycline Cardiomyopathy: Pathophysiology and Case Reports

Abstract

Get full access to this article

View all access options for this article.

References

Gardner, W.D. , and Osburn, W.A. Structure of the Human Body. Philadelphia: W.B. Saunders and Co., 1973, p.326-327.

Lefrak, E.A. , et al. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32:2:302-313, August, 1973.

Bristow, M.R. Toxic cardiomyopathy due to doxorubicin. Hosp. Pract. 17:12:101-111, December, 1982.

Ferrans, V.J. Overview of cardiac pathology in relation to anthracycline cardiotoxicity. Cancer Treat. Rep. 62:6:955-961, June, 1978.

Bristow, M.R. , et al. Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat. Rep. 62:6:873-879, June, 1978.

Bristow, M.R. , et al. Doxorubicin cardiomyopathy: Evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Ann. Intern. Med. 88:2:168-175, February, 1978.

Kushner, J.P. , et al. Cardiomyopathy after widely separated courses of adriamycin exacerbated by Actinomycin-D and mithramycin. Cancer 36:5:1577-1584, November, 1975.

Praga, C. , et al. Adriamycin cardiotoxicity: A survey of 1273 patients. Cancer Treat. Rep. 63:5:827-834, May, 1979.

Mosijczuk, A.D. , et al. Anthracycline cardiomyopathy in children . Cancer 44:5:1582-1587, November, 1979.

10.

Pratt, C.B. , et al. Age-related adriamycin cardiotoxicity in children. Cancer Treat. Rep. 62:9:1381-1385, September, 1978.

11.

Minow, R.A. , et al. Adriamycin cardiomyopathy - Risk factors . Cancer 39:4:1397-1402, April, 1977.

12.

Chiebowski, R.T. , et al. Adriamycin given as a weekly schedule without a loading course: Clinically effective with reduced incidence of cardiotoxicity . Cancer Treat. Rep. 64:1:47-51, January, 1980.

13.

Legha, S.S. , et al. Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann. Intern. Med. 96:2:133-138, February, 1982.

14.

Von Hoff, D.D. , et al. Daunomycin-induced cardiotoxicity in children and adults. Am. J. Med. 62:2:200-208, February, 1977.

15.

Gilladoga, A.C. , et al. The cardiotoxicity of adriamycin and daunomycin in children and adults. Cancer 37:2:1070-1078, February, 1976.

16.

Goorin, A.M. , et al. Congestive heart failure due to adriamycin cardiotoxicity: Its natural history in children. Cancer 47:12:2810-2816, June, 1981.

17.

Von Hoff, D.D. , et al. The cardiotoxicity of anticancer agents . Sem. in Oncol. 9:1: 23-33, March, 1982.

18.

Guyton, Arthur C. Textbook of Medical Physiology, Fourth Ed. Philadelphia : W.B. Saunders and Co., 1971, p.148-152.

19.

Minow, R.A. , et al. QRS voltage change with adriamycin administration . Cancer Treat. Rep. 62:6:931-934, June, 1978.

20.

Biancaniello, T. , et al. Doxorubicin cardiotoxicity in children . J. Pediatr. 97:1:45-50, July, 1980.

21.

Lewis, A.B. , et al. Recovery of left ventricular function following discontinuation of anthracycline chemotherapy in children. Pediatrics 68:1:67-72, July, 1981.

22.

Fulkerson, P.K. , et al. Non-invasive profile in the prospective monitoring of adriamycin cardiomyopathy. Cancer Treat. Rep. 62:6:881-886, June, 1978.

23.

Gottdiener, John S. Non-invasive assessment of cardiac dysfunction in the cancer patient. Cancer Treat. Rep. 62:6:949-953, June, 1978.

24.

Rinehart , et al. Adriamycin cardiotoxicity in man. Ann. Intern. Med. 81:4: 475-478, October, 1974.

25.

Hutchinson, R.J. , et al. Systolic time intervals in monitoring for anthracycline cardiomyopathy in pediatric patients. Cancer Treat. Rep. 62:6:907-910, June, 1978.

26.

Kennedy, J.W. , et al. Radionuclide angiography for the evaluation of anthracycline therapy. Cancer Treat. Rep. 62:6:941-943, June, 1978.

27.

Singer, J.W. , et al. Time and dose dependent changes in ejection fraction determined by radionuclide angiography after anthracycline therapy . Cancer Treat. Rep. 62:6:945-948, June, 1978.

28.

Billingham, M.E. , et al. Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat. Rep. 62:6:865-872, June, 1978.

29.

Friedman, M.A. , et al. Doxorubicin cardiotoxicity - Serial endomyocardial biopsies and systolic time intervals. JAMA 240:15: 1603-1606, October, 1978.

30.

Young, R.C. , et al. The anthracycline antineoplastic drugs . N. Engl. J. Med. 305:3:139-153, July 16, 1981.

31.

Paul, C. , et al. Reducing the cardiotoxicity of anthracyclines by complex-binding to DNA: Report of three cases. Cancer 48:7:1531-1534, October, 1981.

32.

Cortes, E.P. , et al. Adriamycin cardiotoxicity: Early detection by systolic time interval and possible prevention by coenzyme Q10. Cancer Treat. Rep. 62:6:887-891, June, 1978.

33.

Dearth, J. , et al. Anthracycline-induced cardiomyopathy in children: A report of six cases. Med. and Ped. Oncol. 12:1:54-58, January, 1984.